• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [1526 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2010 Canary Health Service [Cost-effectiveness analysis of prostate cancer screening with prostate-specific antigen associated or not with digital rectal examination in men aged 50 years and older]
2009 NIHR Health Technology Assessment programme ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening
2009 NIHR Health Technology Assessment programme How far does screening women for partner violence in different health care settings meet the UK National Screening Committee criteria for a screening programme in terms of condition, screening method and intervention?
2009 NIHR Health Technology Assessment programme Communication of carrier status information following universal newborn screening for sickle cell disorders and cystic fibrosis: qualitative study of experience and practice
2009 NIHR Health Technology Assessment programme The role of magnetic resonance imaging in the identification of suspected acoustic neuroma: systematic review of clinical and cost effectiveness, and natural history
2009 The Netherlands Organisation for Health Research and Development (ZonMw) [Effects and costs of a combined screening and treatment program for elderly (aged 75 years and over) with depressive symptoms in general practice]
2009 NIHR Health Technology Assessment programme Methods to identify postnatal depression in primary care: an integrated evidence synthesis and value of information analysis
2009 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [The relevance of the neonatal urine screening for inborn errors of metabolism performed in Quebec]
2009 Medical Advisory Secretariat (MAS) Screening methods for early detection of colorectal cancers and polyps: summary of evidence-based analyses
2009 Medical Services Advisory Committee (MSAC) Automation-assisted and liquid-based cytology for cervical cancer screening
2009 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Screening mammography for woman aged 40-49: update]
2009 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Information to parents about neonatal screening for inborn errors of metabolism: assessment of current situation and establishment evidence-based information standards]
2009 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Lung cancer screening]
2009 NIHR Health Technology Assessment programme How far does screening women for domestic (partner) violence in different health-care settings meet criteria for a screening programme? Systematic reviews of nine UK National Screening Committee criteria
2009 NIHR Health Technology Assessment programme The role of magnetic resonance imaging in the identification of suspected acoustic neuroma: a systematic review of clinical and cost effectiveness and natural history
2009 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Status quo mammography screening: evaluation results from organised programs
2009 Penn Medicine Center for Evidence-based Practice (CEP) Screening tests for recent heavy alcohol use
2009 NIHR Health Technology Assessment programme Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling
2009 HAYES, Inc. Ancillary urinary cytokeratin (CK) tests for bladder cancer screening and detection
2009 HAYES, Inc. Ancillary urinary microsatellite analysis (MA) for bladder cancer screening and detection
2009 NIHR Health Technology Assessment programme Colour vision testing for diabetic retinopathy: a systematic review of diagnostic accuracy and economic evaluation
2009 Medical Advisory Secretariat (MAS) Magnetic resonance (MR) colonography for colorectal cancer screening: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Capsule endoscopy for colorectal cancer screening: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Flexible sigmoidoscopy for colorectal cancer screening: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Fecal occult blood test for colorectal cancer screening: an evidence-based analysis
2009 Medical Advisory Secretariat (MAS) Computed tomographic (CT) colonography for colorectal cancer screening: an evidence-based analysis
2009 Blue Cross Blue Shield Association (BCBS) CT colonography (virtual colonoscopy) for colon cancer screening
2009 Blue Cross Blue Shield Association (BCBS) Special report: critical appraisal of CT colonography cost-effectiveness analyses
2009 Health Information and Quality Authority (HIQA) Health technology assessment (HTA) of a population-based colorectal cancer screening programme in Ireland
2009 Adelaide Health Technology Assessment (AHTA) Cervista HPV 16/18 for the identification of strains of the human papillomavirus associated with cervical cancer
2009 Adelaide Health Technology Assessment (AHTA) New and emerging technologies for breast cancer detection
2009 Adelaide Health Technology Assessment (AHTA) Rapid testing and targeted population screening for Helicobacter pylori
2009 Adelaide Health Technology Assessment (AHTA) Rapid urine test for Chlamydia trachomatis
2009 Adelaide Health Technology Assessment (AHTA) Breast tomosynthesis: a breast cancer screening tool
2009 Andalusian Health Technology Assessment Area (AETSA) [Diagnostic performance of digital mammography in breast cancer screening]
2009 HAYES, Inc. Breast-specific gamma imaging (BSGI)
2009 HAYES, Inc. Thiopurine S-Methyltransferase (TPMT) genotyping and phenotyping for predicting response to thiopurine drug therapy for Inflammatory Bowel Disease
2009 HAYES, Inc. Microvolt T-Wave Alternans to Identify Risk of Ventricular Arrhythmias and Sudden Cardiac Death
2009 HAYES, Inc. PCA3 detection test for prostate cancer
2009 HAYES, Inc. ColoSure colorectal cancer detection test
2009 HAYES, Inc. deCODE ProstateCancer (deCODE diagnostics)
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal immunochemical tests for colorectal cancer screening of average risk individuals: a systematic review of accuracy and compliance
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Reassessment of health technologies: obsolescence and waste
2009 Andalusian Health Technology Assessment Area (AETSA) [The state of research into inequalities in the incidence, death, prevention and healthcare in cancer in Spain. A bibliometric study and literature review.]
2009 Finnish Office for Health Care Technology Assessment (Finohta) [Evaluation of implementation of foetal screening]
2009 Committee for New Health Technology Assessment (CNHTA) [Microdeletion syndrome screening test(MLPA)]
2009 Committee for New Health Technology Assessment (CNHTA) [TruScreen - cervical cancer screening system]
2009 Agency for Healthcare Research and Quality (AHRQ) Cost-effectiveness of CT colonography to screen for colorectal cancer
2009 Health Information and Quality Authority (HIQA) Report of the evaluation of the use of resources in the national population-based cancer screening programmes and associated services
2009 Health Services Assessment Collaboration (HSAC) Comparison of diagnostic accuracy between immunochemical and guaiac based faecal occult blood tests for colorectal cancer detection: a systematic review of the literature.
2009 Health Services Assessment Collaboration (HSAC) Screening for the early detection of acoustic neuroma in patients with asymmetric sensorineural hearing loss: a rapid literature scan of MRI and other surveillance methods
2009 Health Council of the Netherlands Gezondheidsraad (GR) A national colorectal cancer screening programme
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis
2009 West Midlands Health Technology Assessment Collaboration (WMHTAC) A systematic review of lesbian, gay, bisexual and transgender health in the West Midlands region of the UK compared to published UK research
2009 VA Technology Assessment Program (VATAP) Screening for oral cancer
2009 Basque Office for Health Technology Assessment (OSTEBA) [Health impact assessment of the Integral Regeneration Plan of Uretamendi-Betolaza and beltway]
2009 Agency for Healthcare Research and Quality (AHRQ) Screening for breast cancer: systematic evidence review update for the U.S. Preventive Services Task Force
2009 Agency for Healthcare Research and Quality (AHRQ) Screening for intermediate risk factors for coronary heart disease: systematic evidence synthesis
2009 Agency for Healthcare Research and Quality (AHRQ) Screening for bilirubin encephalopathy
2009 Agency for Healthcare Research and Quality (AHRQ) Screening for visual impairment in older adults: systematic review to update the 1996 U.S. Preventive Services Task Force recommendation
2009 Agency for Healthcare Research and Quality (AHRQ) Screening for child and adolescent depression in primary care settings: a systematic evidence review for the U.S. Preventive Services Task Force
2009 Agency for Healthcare Research and Quality (AHRQ) Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force
2009 Agency for Healthcare Research and Quality (AHRQ) Evaluating test strategies for colorectal cancer screening - age to begin, age to stop, and timing of screening intervals: a decision analysis of colorectal cancer screening for the U.S. Preventive Services Task Force from the Cancer Intervention and Surveillance Modeling Network (CISNET).
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Portable bone mineral density scanners: a review of the clinical effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal immunochemical testing in colorectal cancer screening of average risk individuals: economic evaluation
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Fecal immunochemical tests for colorectal cancer screening: a systematic review of accuracy and compliance
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Universal development assessment tools for children 18-months of age: a review of the clinical effectiveness and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Universal, community-based developmental screening tools for children 6 years and younger: a review of clinical effectiveness
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Foot care for patients with peripheral vascular disease: a review of the guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Urine based testing for gonorrhea and chlamydia: a review of diagnostic accuracy, cost-effectiveness, and compliance
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Pre-operative screening for Methicillin-Resistant Staphylococcus aureus (MRSA) infection: a review of the clinical-effectiveness and guidelines
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) Diagnosis of snoring and obstructive sleep apnea: a review of the accuracy
2009 Canadian Agency for Drugs and Technologies in Health (CADTH) C-reactive protein levels for cardiovascular disease screening: a review of accuracy, use, and guidelines
2009 Institute of Health Economics (IHE) Human papillomavirus (HPV) testing in Alberta
2009 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Screening for haemoglobin disorders among pregnant immigrants – a health technology assessment summary]
2009 Health Sciences Institute in Aragon (IACS) Diabetes complications. Diabetic nephropathy
2009 Health Sciences Institute in Aragon (IACS) Diabetes complications. Diabetic retinopathy
2009 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Screening for defined speech and language development disorders in children]
2009 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Screening for gestational diabetes]
2009 Canary Health Service [Evaluation of the effectiveness and costs of Quantiferon-TB Gold for the diagnosis of latent tuberculosis infection in healthcare personnel]
2008 NIHR Health Technology Assessment programme Accuracy of screening procedures for non-accidental injury in children: systematic review and modelling of clinical effectiveness
2008 NIHR Health Technology Assessment programme Is a screening programme for early age-related macular degeneration likely to be cost-effective? What are the major areas of uncertainty?
2008 Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) [Screening for diabetic retinopathy in Quebec]
2008 NIHR Health Technology Assessment programme Structural brain imaging in first episode psychosis
2008 Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) [Screening for colorectal cancer: the significance of participation rates - a health technology assessment]
2008 Institute of Health Economics (IHE) Risk assessment tools for predicting recidivism of spousal violence
2008 Canadian Agency for Drugs and Technologies in Health (CADTH) Liquid-based techniques for cervical cancer screening: systematic review and cost-effectiveness analysis
2008 Canadian Agency for Drugs and Technologies in Health (CADTH) Octaplas compared with fresh frozen plasma to reduce the risk of transmitting lipid-enveloped viruses: an economic analysis and budget impact analysis
2008 Agency for Healthcare Research and Quality (AHRQ) Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes
2008 NIHR Health Technology Assessment programme Structural neuroimaging in psychosis: a systematic review and economic evaluation
2008 NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and stabismus in children up to the ages of 4-5 years: a systematic review and economic evaluation
2008 NIHR Health Technology Assessment programme A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration
2008 Andalusian Health Technology Assessment Area (AETSA) [Denaturing high performance liquid chromatography (DHPLC). Use and utility in massive genotyping]
2008 Andalusian Health Technology Assessment Area (AETSA) [Utility of PET-FDG in assessing lymphoma. Systematic review of results after chemo and immunotherapy]
2008 Andalusian Health Technology Assessment Area (AETSA) [HER2 in selecting candidates to treatment with Trastuzumab. Determining HER2 status in breast cancer women.]
2008 Andalusian Health Technology Assessment Area (AETSA) [Analysis of RET mutations to perform prophylactic thyroidectomy in individuals at risk for medullary thyroid cancer]
2008 Institute for Clinical and Economic Review (ICER) CT colonography for colorectal cancer screening
2008 The Swedish Council on Health Technology Assessment (SBU) [General childhood vaccination against HPV 16 and 18 aimed at preventing cervical cancer]
2008 The Swedish Council on Health Technology Assessment (SBU) Screening for abdominal aortic aneurysm [update]
2008 Basque Office for Health Technology Assessment (OSTEBA) [Analysis of telemedicine applications in the management-coordination of specialized and primary care. Appraisal of results and costs of pre-existing experiences (teleophthalmology)]